Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial metabolic systems affected by fluoride comprise a group of enzymes and regulatory elements that are sensitive to fluoride ions, primarily targeted to control cariogenic bacteria [1, 5]. The most significant target is the glycolytic enzyme enolase, which is inhibited by a magnesium-fluoride-phosphate complex, leading to reduced energy production and impaired sugar uptake via the phosphotransferase system [1, 2]. Additionally, fluoride inhibits membrane-bound F-type ATPases, which are critical for maintaining intracellular pH; this inhibition results in cytoplasmic acidification and further metabolic suppression [1, 2]. Bacteria also utilize fluoride-specific riboswitches, such as the crcB motif, to sense toxic fluoride levels and induce the expression of efflux transporters for detoxification [3, 4]. These combined effects effectively reduce the acidogenicity and growth of oral pathogens like Streptococcus mutans [1, 3]. The inhibition of these systems is a cornerstone of modern preventive dentistry, particularly through the use of fluoridated water and oral care products [5]. However, therapeutic use is associated with risks such as dental fluorosis and the potential emergence of fluoride-resistant bacterial strains [2, 5]. Understanding these metabolic targets is essential for developing more effective antimicrobial strategies and managing the long-term efficacy of fluoride treatments [1, 3].
Fluoride inhibits bacterial metabolism through several mechanisms: it forms a metal-fluoride complex that inhibits enolase, thereby blocking glycolysis [1]; it inhibits F-type ATPases, leading to cytoplasmic acidification [1, 2]; and it binds to fluoride riboswitches to regulate the expression of fluoride-detoxifying proteins [3, 4].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial metabolic systems affected by fluoride.